1524 / 1674
Ohsumi S, et al. Breast Cancer Res Treat. 2011;127:143–152
Continuation of tamoxifen treatment after
adjuvant tamoxifen for 1–4 years may provide
Japanese breast cancer patients with better
HRQOL than by switching to anastrozole.
Less local treatment: where is the limit?
Side effects